Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santini, S.M.
Right arrow Articles by Belardelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santini, S.M.
Right arrow Articles by Belardelli, F.

Stem Cells 2003;21:357-362 www.StemCells.com
© 2003 AlphaMed Press


MEETING REPORT

A New Type I IFN-Mediated Pathway for the Rapid Differentiation of Monocytes into Highly Active Dendritic Cells

S.M. Santini, T. Di Pucchio, C. Lapenta, S. Parlato, M. Logozzi, F. Belardelli

Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy

Key Words. Dendritic cells • Type I IFN • APC • Vaccines

S.M. Santini, Ph.D., Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy. Telephone: 39-06-4990-3290; Fax: 39-06-4990-2097; e-mail: ssant{at}iss.it

Dendritic cells (DCs) are a unique leukocyte type consisting of different subsets of professional antigen-presenting cells. Since DCs initiate and govern the immune response, they represent an ideal target for intervention aimed at modulating and potentiating immune responses against cancer and infectious diseases. We recently described and characterized, at a functional level, a novel DC subset, interferon (IFN)-DCs, derived from blood monocytes after a short exposure to type I IFN and GM-CSF. Here, we review our recent studies on IFN-DCs and discuss their possible use in clinical immunotherapeutic strategies.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
L. F. Zhang, K. Okuma, R. Tanaka, A. Kodama, K. Kondo, A. A. Ansari, and Y. Tanaka
Generation of Mature Dendritic Cells with Unique Phenotype and Function by In Vitro Short-Term Culture of Human Monocytes in the Presence of Interleukin-4 and Interferon-{beta}
Experimental Biology and Medicine, June 1, 2008; 233(6): 721 - 731.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Teleshova, J. Kenney, V. Williams, G. Van Nest, J. Marshall, J. D. Lifson, I. Sivin, J. Dufour, R. Bohm, A. Gettie, et al.
CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques
J. Leukoc. Biol., February 1, 2006; 79(2): 257 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Breckpot, J. Corthals, A. Bonehill, A. Michiels, S. Tuyaerts, C. Aerts, C. Heirman, and K. Thielemans
Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell response
J. Leukoc. Biol., October 1, 2005; 78(4): 898 - 908.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Balmelli, N. Ruggli, K. McCullough, and A. Summerfield
Fibrocytes are potent stimulators of anti-virus cytotoxic T cells
J. Leukoc. Biol., June 1, 2005; 77(6): 923 - 933.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Mariotti, R. Teloni, E. Iona, L. Fattorini, G. Romagnoli, M. C. Gagliardi, G. Orefici, and R. Nisini
Mycobacterium tuberculosis Diverts Alpha Interferon-Induced Monocyte Differentiation from Dendritic Cells into Immunoprivileged Macrophage-Like Host Cells
Infect. Immun., August 1, 2004; 72(8): 4385 - 4392.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Teleshova, J. Kenney, J. Jones, J. Marshall, G. Van Nest, J. Dufour, R. Bohm, J. D. Lifson, A. Gettie, and M. Pope
CpG-C Immunostimulatory Oligodeoxyribonucleotide Activation of Plasmacytoid Dendritic Cells in Rhesus Macaques to Augment the Activation of IFN-{gamma}-Secreting Simian Immunodeficiency Virus-Specific T Cells
J. Immunol., August 1, 2004; 173(3): 1647 - 1657.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. R. Migliaccio, R. Quarto, and W. Piacibello
Cell Therapy: Filling the Gap Between Basic Science and Clinical Trials October 15-17, 2001, Rome, Italy
Stem Cells, May 1, 2003; 21(3): 348 - 356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 2003 by AlphaMed Press.